A report of the efforts of the veterans health administration national antimicrobial stewardship initiative

Infection Control and Hospital Epidemiology

Volumn 38, Issue 5, 2017, Pages 513-520

  Kelly, Allison A ^a,b   Jones, Makoto M ^a,c   Echevarria, Kelly L ^d,e,f   Kralovic, Stephen M ^a,b   Samore, Matthew H ^a,c   Goetz, Matthew B ^g,h   Madaras Kelly, Karl J ^i,j   Simbartl, Loretta A ^a   Morreale, Anthony P ^a   Neuhauser, Melinda M ^a   Roselle, Gary A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^g VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Boise VA Medical Center   (United States)

^j IDAHO STATE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; QUINOLONE DERIVATIVE; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL STEWARDSHIP PROGRAM; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; GRAM NEGATIVE INFECTION; HEALTH CARE DISTRIBUTION; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOSPITAL READMISSION; HUMAN; MORTALITY RATE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRESCRIPTION; VETERANS HEALTH; BACTERIAL INFECTIONS; DRUG UTILIZATION; EVALUATION STUDY; GOVERNMENT; INAPPROPRIATE PRESCRIBING; PRACTICE GUIDELINE; PROGRAM EVALUATION; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; HUMANS; INAPPROPRIATE PRESCRIBING; PRACTICE GUIDELINES AS TOPIC; PROGRAM EVALUATION; SURVEYS AND QUESTIONNAIRES; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 85017585105     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2016.328     Document Type: Article

References (18)

1. Antibiotic resistance threats in the United States. 2013. Centers for Disease Control and Prevention website. http://www.cdc.gov/drugresistance/threat-report-2013/. Published 2013. Accessed March 20, 2015.
2. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099-1106.
3. Talon D, Bailly P, Bertrand X, Thouverez M, Mulin B. Clinical and molecular epidemiology of chromosome-mediated resistance to third generation cephalosporins in Enterobacter isolates in eastern France. Clin Micro Infect 2000;6:374-382.
4. Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 2008;15:735-743.
5. Chang HT, Krezolek D, Johnson S, Parada JP, Evans CT, Gerding DN. Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital. Infect Control Hosp Epidemiol 2007;28:926-931.
6. VHA Directive 1031: Antimicrobial Stewardship Programs. http://www.va.gov/vhapublications/ViewPublication.asp?pub-ID=2964. Published 2014. Accessed March 17, 2015.
7. VHA Under-Secretary for Health's (USH's) information letter on antimicrobial stewardship. http://vaww.vhaco.va.gov/pubarchives/docs/IL-10-2012-011.pdf. Internal VA intranet website. Accessed March 17, 2015.
8. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007;44:664-670.
9. Evans ME, Kralovic SM, Simbartl LA, Jain R, Roselle GA. Effect of a Clostridium difficile infection prevention initiative in Veterans Affairs acute-care facilities. Infect Control Hosp Epidemiol 2016;37:720-722.
10. Reeves JS, Evans ME, Simbartl LA, Kralovic SM, Kelly AA, Jain R, Roselle GA. Clostridium difficile infections in Veterans Health Administration long-term care facilities. Infect Control Hosp Epidemiol 2016;37:295-300.
11. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, Laxminarayan R. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 2014;14:742-750.
12. Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44:159-177.
13. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003;163: 972-978.
14. Hicks LA, Taylor TH, Hunkler RJ. US outpatient antibiotic prescribing, 2010. N Engl J Med 2013;368:1461-1462.
15. Polk RE, Hohmann SF, Medvedev S, Ibrahim O. Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals. Clin Infect Dis 2011;53:1100-1110.
16. Baggs J, Fridkin SK, Pollack LA, Srinivasan A, Jernigan JA. Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012. JAMA Intern Med 2016;176: 1639-1648.
17. Chou AF, Graber CJ, Jones M, et al. Characteristics of antimicrobial stewardship programs at Veterans Affairs hospitals: results of a nationwide survey. Infect Control Hosp Epidemiol 2016;37:647-654.
18. TheWhite House's national action plan for combatting antibioticresistant bacteria. The White House website. https://www.whitehouse.gov/sites/default/files/docs/national-action-plan-for- combating-antibotic-resistant-bacteria.pdf. Published 2015. Accessed November 28, 2016.